InterVapor System
Severe Emphysema / Lung Volume Reduction
Approved (CE Mark, NMPA China)Active
Key Facts
Indication
Severe Emphysema / Lung Volume Reduction
Phase
Approved (CE Mark, NMPA China)
Status
Active
Company
About Broncus Medical
Broncus Medical is a private medical device company pioneering minimally invasive treatments for lung diseases, primarily targeting COPD and lung cancer. Its technology platform centers on catheter-based systems for lung volume reduction and transbronchial ablation of peripheral lung nodules. The company has achieved regulatory approvals (CE Mark, NMPA China) for its flagship LungPoint planning system and Archimedes navigation platform, and is advancing its therapeutic devices through clinical studies. Broncus operates in the large and growing interventional pulmonology market, competing against larger medtech players while seeking to establish its novel therapeutic approaches as standards of care.
View full company profile